Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 15, 2015 - Issue 11
Submit an article Journal homepage
653
Views
11
CrossRef citations to date
0
Altmetric
Drug profile

Topical amitriptyline and ketamine for the treatment of neuropathic pain

Sebastiano MercadanteAnesthesia & Intensive Care and Pain Relief & Palliative Care Unit, La Maddalena Cancer Center,Palermo, ItalyCorrespondence[email protected]
Pages 1249-1253 | Published online: 21 Oct 2015

References

  • Driessen CM, Kleine-Bolt KM, Vingerhoets AJ, et al. Assesssing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients. Support Care Cancer. 2012;20:877–881.
  • Martin LGR, Silva MDP. Chemotherapy induced peripheral neuropathy: a literature review. Einstein. 2011;9:538–544.
  • Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Expert Opin Drug Saf. 2004;3:535–546.
  • Afonseca SO, Silva MAC, Giglio AD. Abordagem da neuropatia periférica induzida por quimioterapia. Rev Bras Med. 2010;67(n.esp):20–25.
  • Grothey A, Nikcevich DA, Sloan JA, et al. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol. 2011;29:421–427.
  • Kopsky DJ, Hesselink JM. High doses of topical amitriptyline in neuropathic pain: two cases and literature review. Pain Pract. 2012;12:148–153.
  • Verdu B, Decpsterd I, Buclin T, et al.Antidepressants for the treatment of chronic pain. Drugs. 2008;68:2611–2632.
  • Thompson DF, Brooks KG. Systematic review of topical amitriptyline for the treatment of neuropathic pain. J Clin Pharm Ther. 2015. DOI:10.1111/jcpt.12297. Epub ahead of print.
  • Sawynok J. Topical and peripheral ketamine as an analgesic. Anesth Analg. 2014;119:170–178.
  • Gerner P, Kao G, Srinivasa V, et al. Topical amitriptyline in healthy volunteers. Reg Anesth Pain Med. 2003;28:289–293.
  • Guirimand F, Dupont X, Brasseur L, et al. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesth Analg. 2000;90:408–414.
  • Niesters M, Aarts L, Sarton E, et al. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of concept study. Br J Anaesth. 2013;110:1010–1016.
  • De Kock M, Loix S, Lavand’homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther. 2013;19:403–410.
  • Gammaitoni A, Gallagher RM, Welz-Bosna M. Topical ketamine gel: possible role in teating neuropathic pain. Pain Med. 2000;1:97–100.
  • Mahoney JM, Vardaxis V, Moore JL, et al. Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study. J Am Pediatr Med Assoc. 2012;102:178–183.
  • Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain. 2009;146:18–25.
  • Kopsky DJ, Keppel Hesselink JM, Bhaskar A, et al. Analgesic effects of topical ketamine. Minerva Anesthesiol. 2015;81:440–449.
  • Somberg JC, Molnar J. Retrospective study on the analgesic activity of a topical (TT-CTAC) cream in patients with diabetic neuropathy and other chronic pain conditions. Am J Ther. 2015;22:214–221.
  • Barton DL, Wos EJ, Qin R, et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011;19:833–841.
  • Uzaraga I, Gerbis B, Holwerda E, et al. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study. Support Care Cancer. 2012;20:1515–1524.
  • Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003;19:323–328.
  • Lynch ME, Clark AJ, Sawynok J, et al. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain. 2005;6:644–649.
  • Poterucha TJ, Murphy SL, Rho RH, et al. Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort. Pain Physician. 2012;15:485–488.
  • Gewandter JS, Mohile SG, Heckler CE, et al. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer. 2014;22:1807–1814.
  • Lynch ME, Clark AJ, Sawynok J, et al. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103:140–146.
  • Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain. 2004;5:S182.
  • Ho KY, Huh BK, White WD, et al. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24:51–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.